期刊文献+

聚(DL-丙交酯-co-ε-己内酯)的合成、结构与性能研究 被引量:3

Synthesis,microstructure and properties of poly(DL-lactide-co-ε-caprolactone) obtained by magnesium octoate
下载PDF
导出
摘要 以辛酸镁为催化剂催化DL-丙交酯和ε-己内酯本体开环共聚合,制备了一系列不同单体配比的共聚物1。3CNMR分析了共聚物微观结构,计算各单元平均序列长度,表明两类酯交换反应存在使得单元序列结构重新分布,并趋向于无规化分布;共聚物组成显著影响单元序列长度,各序列长度随相应单体加入量增加而增长。DSC和XRD分析了共聚物热性能和结晶性,表明共聚物结晶性与单元序列长度密切相关。共聚物只观察到一个玻璃化转变温度,符合无规共聚物的Fox方程,说明所得共聚物为无规共聚物,或者说包含有相容性嵌段成分的共聚物。 Poly(DL-lactide-co-ε-caprolactone) copolymers were prepared by copolymerization of DL-LA and ε-CL using nontoxic magnesium octoate as catalyst in bulk. Microstrueture analyses of the resulting copolymers were performed by means of ^13 CNMR spectroscopy. Two modes of transesterifieation occurred during the copolymerization process and played an important role in the redistribution of comonomer sequences toward randomness. The copolymer composition has a profound influence on the average block length of lactidyl and eaproyl units (LLL^e and Lec). Both LLL^e and Lc^e increased as the relative proportions of their respective monomers increased. The thermal properties and crystallization of the copolymers were investigated by DSC and XRD. The results showed that a close relationship between copolymer erystallinity and the length of the copolymer sequences. All the eopolymers exhibited a single Tg. The experimental Tgs were in agreement with the calculated values from Fox equation. It can be concluded that the eopolymers are random, or comprise a mixture of compatible block copolymers.
出处 《功能材料》 EI CAS CSCD 北大核心 2009年第1期123-125,129,共4页 Journal of Functional Materials
关键词 聚(DL-丙交酯-co-ε-己内酯) 辛酸镁 微观结构 性能 Poly(DL-lactide-co-ε-caprolactone) Magnesium octoate Microstructure Properties
  • 相关文献

参考文献13

二级参考文献34

共引文献12

同被引文献40

  • 1王庆蓉,王华芬,冯俊,卓仁禧,程巳雪.生物可降解脂肪族聚碳酸酯功能化研究进展[J].高分子材料科学与工程,2015,31(2):185-190. 被引量:3
  • 2申雄军,陈晓峰,李贤.高分子质量聚(L-丙交酯-co-己内酯)无规共聚物的制备及性能[J].高分子材料科学与工程,2015,31(6):1-6. 被引量:3
  • 3杨永坤,汤朝晖,庞烜,杜鸿志,陈学思,景遐斌.非手性席夫碱-异丙氧基铝引发外消旋丙交酯的立构选择性聚合[J].高等学校化学学报,2006,27(2):352-355. 被引量:4
  • 4唐丽娜,宋存先,孙洪范,冷希岗,梅林.医用聚己内酯埋植剂体内降解的研究[J].生物医学工程与临床,2007,11(4):263-267. 被引量:8
  • 5Kammerer M,Fabritius M,Carvalho C. Valproate release from polycaprolactone implants prepared by 3D-bioplotting[J].Die Pharmazie,2011,(07):511-516.
  • 6Elomaa L,Teixeira S,Hakala R. Preparation of poly(ε-caprolactone)-based tissue engineering scaffolds by stereolithography[J].Acta Biomaterialia,2011,(11):3850-3856.
  • 7Valmikinathan CM,Defroda S,Yu X. Polycaprolactone and bovine serum albumin based nanofibers for control ed release of nerve growth factor[J].Biomacromolecules,2009,(05):1084-1089.
  • 8Fernandez JM,Molinuevo MS,Cortizo AM. Characterization of poly(epsilon-caprolactone)/polyfumarate blends as scaffolds for bone tissue engineering[J].Journal of Biomaterials Science:Polymer Edition,2010,(10):1297-1312.
  • 9Cohn D,Salomon AH. Designing biodegradable multiblock PCL/PLA thermoplastic elastomers[J].Biomaterials,2005,(15):2297-2305.
  • 10Casper ME,Fitzsimmons JS,Stone JJ. Tissue engineering of cartilage using poly-epsilon-caprolactone nanofiber scaffolds seeded in vivo with periosteal cel s[J].Osteoarthritis and Cartilage,2010,(07):981-091.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部